Colorectal cancer

A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma.

Aliases

cancer of colorectum
cancer of large bowel
cancer of large intestine
cancer of the large bowel
colon cancer
colorectal cancer
colorectal cancer
colorectal cancer
colorectum cancer
CRC
large intestine cancer
malignant colorectal neoplasm
malignant colorectal tumor
malignant colorectum neoplasm
malignant large bowel neoplasm
malignant large bowel tumor
malignant large intestine neoplasm
malignant large intestine tumor
malignant neoplasm of colorectum
malignant neoplasm of large bowel
malignant neoplasm of large intestine
malignant neoplasm of the large bowel
malignant neoplasm of the large intestine
malignant tumor of large bowel
malignant tumor of large intestine
malignant tumor of the large bowel
malignant tumor of the large intestine

Studies related to Colorectal cancer Advanced search

A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer

Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer

Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer

Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples

Altered intestinal microbiota associated with colorectal cancer

Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India

Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment

Changes in Bacteroides and the microbiota in patients with obstructed colorectal cancer: retrospective cohort study

Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study

Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites

Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers

Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing

Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers

Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy

Correlation of gut microbiota with leukopenia after chemotherapy in patients with colorectal cancer

Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers

Different Characteristics in Gut Microbiome between Advanced Adenoma Patients and Colorectal Cancer Patients by Metagenomic Analysis

Dysbiosis of human gut microbiome in young-onset colorectal cancer

Dysbiosis signature of fecal microbiota in colorectal cancer patients

Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients

Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway

Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Gut microbiome of Moroccan colorectal cancer patients

Gut microbiota display alternative profiles in patients with early-onset colorectal cancer

Gut microbiota in patients after surgical treatment for colorectal cancer

Gut mucosal microbiome across stages of colorectal carcinogenesis

Human gut microbiome and risk for colorectal cancer

Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer

Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer

Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer

Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention

Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity

Long-term follow-up of colorectal cancer screening attendees identifies differences in Phascolarctobacterium spp. using 16S rRNA and metagenome sequencing

Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer

Metagenomic analyses of the gut microbiota associated with colorectal adenoma

Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation

Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer

Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients

Microbiota disbiosis is associated with colorectal cancer

Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon

Oral microbiome and history of smoking and colorectal cancer

Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients

Potential of fecal microbiota for early-stage detection of colorectal cancer

Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study

Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk

Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis

Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults

Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers

Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing

The efficacy of prevention for colon cancer based on the microbiota therapy and the antitumor mechanisms with intervention of dietary Lactobacillus

The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer

The human gut microbiome as a screening tool for colorectal cancer

The oral microbiota in colorectal cancer is distinctive and predictive

Tumour-associated and non-tumour-associated microbiota in colorectal cancer

Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment